New ways to stop osteosarcoma from spreading
Official title: Revealing Metastatic Tumor Microenvironmental Mechanisms in Osteosarcoma to Develop Novel Therapeutic Approaches
Funded at Research Inst Nationwide Children's Hosp · NIH-11444426 · Data updated 2026-11-12
Researchers are testing new approaches to block how osteosarcoma spreads, with the aim of improving survival for children and adults with metastatic disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $146,779 |
| NIH project number | 1R50CA315376-01 |
| Project ID | NIH-11444426 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals with or at risk of metastatic osteosarcoma, including pediatric and young adult patients.
✕Less likely to help
Patients without metastatic disease or those unlikely to respond to the targeted therapies may not benefit.
What this research studies
This project focuses on understanding how osteosarcoma cells interact with surrounding cells in the lungs to spread and form metastases. It uses mouse models to test drugs that interrupt these harmful signals and reduce metastatic tumors. The team plans to translate these findings toward clinical applications, potentially offering new treatment options for patients whose cancer has spread. The work blends biology and computational analysis to identify vulnerable pathways that could be targeted in future trials.
Why it matters
Potential benefit: If successful, patients with metastatic osteosarcoma could gain new therapy options that limit spread and improve survival.
How similar studies have gone: Previous studies have shown that targeting tumor–microenvironment interactions can reduce metastasis in preclinical models, supporting potential translational value.
Where this research is happening
-
Research Inst Nationwide Children's Hosp
Columbus, United States Active
Researchers
- Principal investigator: Cannon, Matthew Vinson — Research Inst Nationwide Children's Hosp
- Study coordinator: Cannon, Matthew Vinson
Related research
Other NIH-funded projects on the same topics.
-
Understanding how bone cancer cells rely on certain pathways to grow in childhood osteosarcoma
This grant studies how specific cancer-related pathways in bone-forming cells drive osteosarcoma in children, with the aim of finding better treatments.
-
Histotripsy + immune boost to fight osteosarcoma
A new treatment idea combines a precise non-surgical ultrasound method with an immune-boosting compound to help fight bone cancer in people and dogs.
-
Genomically guided drug testing for osteosarcoma in patient-derived models
A precision approach tests new drugs on osteosarcoma models created from patients to find promising treatments for kids and teens.
-
Targeting OST Redundancy to Treat Osteosarcoma
A study in people with advanced bone cancer to see if new OST-targeting drugs can slow or stop tumor growth.
-
Focal Adhesion Kinase inhibitor to block osteosarcoma spread to the lungs
A cancer treatment plan tests whether blocking a specific cell signal can stop osteosarcoma from growing and spreading to the lungs in kids and young people.
-
Canine osteosarcoma immunity boost from hyperactivated dendritic cells
A study tests a way to spark a strong anti-tumor immune response in dogs with bone cancer using highly activated immune cells.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.